Short Interest in Elekta AB (publ) (OTCMKTS:EKTAY) Increases By 300.0%

Elekta AB (publ) (OTCMKTS:EKTAY) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 400 shares, an increase of 300.0% from the February 28th total of 100 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 22,500 shares, the days-to-cover ratio is presently 0.0 days.

Elekta AB (publ) Stock Down 0.7 %

Shares of Elekta AB (publ) stock traded down $0.04 during trading hours on Friday, hitting $5.34. The company had a trading volume of 16,185 shares, compared to its average volume of 9,649. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.05 and a quick ratio of 0.81. The company’s 50-day moving average is $5.76 and its two-hundred day moving average is $5.93. The company has a market cap of $2.05 billion, a P/E ratio of 21.35 and a beta of 1.25. Elekta AB has a twelve month low of $5.25 and a twelve month high of $8.24.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its quarterly earnings data on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. The company had revenue of $416.86 million during the quarter, compared to analyst estimates of $435.89 million. Analysts anticipate that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The company also recently declared a dividend, which was paid on Thursday, March 27th. Investors of record on Friday, March 7th were paid a dividend of $0.1072 per share. The ex-dividend date of this dividend was Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is presently 44.00%.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research report on Wednesday, January 29th.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.